Expression of 25-hydroxyvitamin D3-1α-hydroxylase in subcutaneous fat necrosis

• Published in: British journal of dermatology (1951) Vol. 160; no. 2; pp. 423 - 425
• Main Authors: Farooque, A., Moss, C., Zehnder, D., Hewison, M., Shaw, N.J.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.02.2009; Wiley-Blackwell
• Subjects: Biological and medical sciences; Dermatology; hypercalcaemia; Medical sciences; subcutaneous fat necrosis; vitamin D; Hypercalcemia; Hydroelectrolytic balance disorder; Metabolic disorder; Adipose tissue; Calcium; Vitamin D; Dermatology; Subcutaneous; Inorganic element; Necrosis; hypercalcaemia; subcutaneous fat necrosis
• ISSN: 0007-0963; 1365-2133
• DOI: 10.1111/j.1365-2133.2008.08844.x

Summary Background  The most serious complication of subcutaneous fat necrosis (SCFN), a rare condition of the newborn characterized by indurated purple nodules, is hypercalcaemia. However, the mechanism for this hypercalcaemia remains unclear. Objectives  To determine whether the hypercalcaemia associated with SCFN involves expression of the vitamin D‐activating enzyme 25‐hydroxyvitamin D3‐1α‐hydroxylase (1α‐hydroxylase) in affected tissue. Methods  Skin biopsies from two male patients with SCFN and hypercalcaemia were taken. The histological specimens were assessed using a polyclonal antibody against 1α‐hydroxylase. Results  Histology in both cases showed strong expression of 1α‐hydroxylase protein (brown staining) within the inflammatory infiltrate associated with SCFN. This was consistent with similar experiments in other granulomatous conditions. Conclusions  Hypercalcaemia in SCFN appears to be due to abundant levels of 1α‐hydroxylase in immune infiltrates associated with tissue lesions. This is consistent with previous observations of extrarenal 1α‐hydroxylase in skin from other granulomatous conditions such as sarcoidosis and slack skin disease.